A baby monitor that reads oxygen and pulse. Its regulatory history is the important part: it drew an FDA warning letter before later achieving clearance as a medical device.
This entry is written from the 4 sources listed at the bottom of the page. The numbers are our editorial estimates drawn from that material, not measurements, and no statistical sample sits behind them.
It depends on how you will use it. 64% would buy it again, which means roughly 36% would not. False alerts are the most common complaint.
Reassurance value falls as confidence grows, and the alerts that remain are mostly false ones — which is when parents stop using it.
False alerts are the most common complaint. No monitor prevents the outcomes parents fear most. The useful window is short relative to the cost.
Worth it for: Anxious first-time parents; Families with a specific clinical reason to monitor; Parents who will interpret alerts calmly. Think twice if: You would be woken by false alarms nightly; Anxiety would be increased by more data; The price is hard to justify for months of use.
Our reading of how sentiment moves across an ownership period, drawn from the sources below. It is an editorial estimate, not tracked longitudinal data.
| At purchase | 7.7 / 10 |
|---|---|
| First week | 8.3 / 10 |
| One month | 7.5 / 10 |
| Six months | 7.1 / 10 |
| One year | 7.0 / 10 |
| Two years or more | 7.0 / 10 |
Owner reviews move this score. The researched figure stays visible next to it, so you can always see what the sources said before anyone voted.
Leave a review on the live pageEvery complaint and every piece of praise above traces back to these. The summaries are ours; nothing is quoted, and no link, quote or username anywhere on this site is invented.
The company's own response to the regulator's communication.
Coverage of the FDA warning letter and its impact.
The later clearance as a medical-grade infant pulse oximeter.
Parent-perspective review of alerts and daily use.